213 related articles for article (PubMed ID: 6620266)
1. Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis.
Miller ML; Lantner R; Pachman LM
J Rheumatol; 1983 Aug; 10(4):640-2. PubMed ID: 6620266
[TBL] [Abstract][Full Text] [Related]
2. Comparison of natural killing with antibody dependent cell mediated cytotoxicity in patients with systemic lupus erythematosus.
Kozlowski SH; Hirsen DJ; Jackson EJ
J Rheumatol; 1982; 9(1):59-62. PubMed ID: 7086780
[TBL] [Abstract][Full Text] [Related]
3. Effects of serum from patients with system lupus erythematosus on leukocyte cytotoxicity: modulation of NK activity and ADCC.
Ytterberg SR; Huard TK; Schnitzer TJ
J Rheumatol; 1983 Dec; 10(6):906-12. PubMed ID: 6663595
[TBL] [Abstract][Full Text] [Related]
4. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus.
Yabuhara A; Yang FC; Nakazawa T; Iwasaki Y; Mori T; Koike K; Kawai H; Komiyama A
J Rheumatol; 1996 Jan; 23(1):171-7. PubMed ID: 8838528
[TBL] [Abstract][Full Text] [Related]
5. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
Ewan PW; Barrett HM; Pusey CD
J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
[TBL] [Abstract][Full Text] [Related]
6. Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.
Oshimi K; Gonda N; Sumiya M; Kano S
Clin Exp Immunol; 1980 Apr; 40(1):83-8. PubMed ID: 7389219
[TBL] [Abstract][Full Text] [Related]
7. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
[TBL] [Abstract][Full Text] [Related]
9. Antibody dependent cellular cytotoxicity of lymphocytes in patients with renal diseases of immunopathological origin.
Láng I; Kenéz B; Nagy ZK; Sonkoly I; Pálóczi K; Szegedi G; Fekete B; Gergely P
Clin Nephrol; 1978 Mar; 9(3):111-4. PubMed ID: 565267
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.
Kumagai S; Steinberg AD; Green I
J Clin Invest; 1981 Mar; 67(3):605-14. PubMed ID: 6970750
[TBL] [Abstract][Full Text] [Related]
11. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
Clin Dev Immunol; 2006; 13(2-4):283-7. PubMed ID: 17162369
[TBL] [Abstract][Full Text] [Related]
12. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.
Park YW; Kee SJ; Cho YN; Lee EH; Lee HY; Kim EM; Shin MH; Park JJ; Kim TJ; Lee SS; Yoo DH; Kang HS
Arthritis Rheum; 2009 Jun; 60(6):1753-63. PubMed ID: 19479851
[TBL] [Abstract][Full Text] [Related]
13. Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors.
Zippel D; Lackovic V; Kocisková D; Rovenský J; Borecký L; Stelzner A
Acta Virol; 1989 Sep; 33(5):447-53. PubMed ID: 2483602
[TBL] [Abstract][Full Text] [Related]
14. Natural and antibody-dependent cellular cytotoxicity in patients with active sarcoidosis.
Antonaci S; Moretti AM; Bonomo L
Allergol Immunopathol (Madr); 1983; 11(1):40-6. PubMed ID: 6858806
[TBL] [Abstract][Full Text] [Related]
15. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
16. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
17. Decreased DAP12 expression in natural killer lymphocytes from patients with systemic lupus erythematosus is associated with increased transcript mutations.
Toyabe S; Kaneko U; Uchiyama M
J Autoimmun; 2004 Dec; 23(4):371-8. PubMed ID: 15571931
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell activity in dermatomyositis-polymyositis.
Gonzalez-Amaro R; Alcocer-Varela J; Alarcón-Segovia D
J Rheumatol; 1987 Apr; 14(2):307-10. PubMed ID: 3496455
[TBL] [Abstract][Full Text] [Related]
19. Family study of natural killer cell activity in C1q-deficient patients with systemic lupus erythematosus-like syndrome: association between impaired natural killer cell function and C1q deficiency.
Tóth J; Starsia Z; Buc M; Stefanovic J
Immunobiology; 1989 Nov; 180(1):47-54. PubMed ID: 2625354
[TBL] [Abstract][Full Text] [Related]
20. CD5 positive B lymphocytes in seronegative juvenile arthritis.
Martini A; Massa M; De Benedetti F; Viola S; Neirotti G; Burgio RG
J Rheumatol; 1990 Jul; 17(7):932-5. PubMed ID: 1698986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
